Award recognizes the groundbreaking science of Dupixent and its transformational impact on multiple rare and common allergic and atopic ...

Tori Spelling shares her and her family’s journey with eczema and seborrheic dermatitis to encourage others to take control of their skin ...

TV and movie star Julie Bowen has good news for chronic dry eye sufferers: With the right treatment, relief may be in sight.

From swelling to varicose veins, Charles Leithead, MD, of Ochsner Health, explains why patients should not ignore signs of ...

In medicine, treatment goals set by physicians might differ from patient priorities. Although normalisation of laboratory parameters is a target supported by outcomes data, patient perspectives ...

Treatment for chronic hives lasting at least 6 weeks may include one or more types of medication, as well as certain ...

Dry, chapped, itchy lips can be uncomfortable. Learn the most-common causes of itchy lips, plus ways to find relief.

Your research highlights the increased mortality risk in patients with chronic spontaneous urticaria (CSU), particularly from comorbidities like suicide and malignant neoplasms. What are the key ...

Objectives The objective of our study was to assess the benefits and harms of tramadol vs placebo in adults with chronic pain. Design The research method was a systematic review of randomised clinical ...

Researchers believe they have developed the first dedicated blood test to diagnose chronic fatigue syndrome (CFS), also known as myalgic encephalomyelitis (ME), which has the potential to be a ...

Novartis has secured FDA approval for its BTK inhibitor remibrutinib (Rhapsido) for the treatment of chronic spontaneous urticaria. Remibrutinib is the sixth BTK inhibitor to market in the US, and the ...